As of 2025-12-16, the Relative Valuation of Aclaris Therapeutics Inc (ACRS) is (23.54) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.17 USD, the upside of Aclaris Therapeutics Inc based on Relative Valuation is -842.5%.
The range of the Relative Valuation is (21.99) - (24.87) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.4x - 19.0x | 16.8x |
| Forward P/E multiples | 16.8x - 20.1x | 19.2x |
| Fair Price | (21.99) - (24.87) | (23.54) |
| Upside | -793.8% - -884.6% | -842.5% |
| Date | P/E |
| 2025-12-15 | -2.55 |
| 2025-12-12 | -2.49 |
| 2025-12-11 | -2.57 |
| 2025-12-10 | -2.50 |
| 2025-12-09 | -2.45 |
| 2025-12-08 | -2.51 |
| 2025-12-05 | -2.23 |
| 2025-12-04 | -2.30 |
| 2025-12-03 | -2.13 |
| 2025-12-02 | -2.06 |
| 2025-12-01 | -2.00 |
| 2025-11-28 | -2.16 |
| 2025-11-26 | -2.20 |
| 2025-11-25 | -2.09 |
| 2025-11-24 | -2.10 |
| 2025-11-21 | -1.92 |
| 2025-11-20 | -1.84 |
| 2025-11-19 | -1.88 |
| 2025-11-18 | -1.90 |
| 2025-11-17 | -1.87 |
| 2025-11-14 | -1.93 |
| 2025-11-13 | -1.77 |
| 2025-11-12 | -1.84 |
| 2025-11-11 | -1.76 |
| 2025-11-10 | -1.63 |
| 2025-11-07 | -1.77 |
| 2025-11-06 | -1.74 |
| 2025-11-05 | -1.73 |
| 2025-11-04 | -1.80 |
| 2025-11-03 | -1.96 |
| 2025-10-31 | -1.93 |
| 2025-10-30 | -1.90 |
| 2025-10-29 | -1.79 |
| 2025-10-28 | -1.83 |
| 2025-10-27 | -1.79 |
| 2025-10-24 | -1.64 |
| 2025-10-23 | -1.73 |
| 2025-10-22 | -1.73 |
| 2025-10-21 | -1.82 |
| 2025-10-20 | -1.54 |
| 2025-10-17 | -1.45 |
| 2025-10-16 | -1.57 |
| 2025-10-15 | -1.48 |
| 2025-10-14 | -1.38 |
| 2025-10-13 | -1.46 |
| 2025-10-10 | -1.43 |
| 2025-10-09 | -1.49 |
| 2025-10-08 | -1.45 |
| 2025-10-07 | -1.41 |
| 2025-10-06 | -1.45 |